When Should Preoperative Short-Course Radiotherapy or Long-Course Chemoradiotherapy Be Performed?

Chapter

Abstract

Traditionally, there has been a high local recurrence rate after radical surgery in rectal cancer, and 10–40% of patients require a permanent stoma. Both short-course preoperative radiotherapy (SCPRT) and long-course preoperative chemoradiation (CRT) are advocated to reduce this risk of local recurrence and enable a curative resection. The role of preoperative radiotherapy to facilitate sphincter sparing surgery remains highly contentious.

Keywords

Rectal Cancer Total Mesorectal Excision Late Toxicity Circumferential Resection Margin Mesorectal Fascia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336(14):980–987Google Scholar
  2. 2.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMedCrossRefGoogle Scholar
  3. 3.
    Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666):811–820PubMedCrossRefGoogle Scholar
  4. 4.
    Tiefenthal M, Nilsson PJ, Johansson R, Glimelius B, Pahlman L (2011) The effects of short-course preoperative irradiation on local recurrence rate and survival in rectal cancer: a population-based nationwide study. Dis Colon Rectum 54(6):672–680PubMedCrossRefGoogle Scholar
  5. 5.
    Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 358(9290):1291–1304CrossRefGoogle Scholar
  6. 6.
    Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620–4625PubMedCrossRefGoogle Scholar
  7. 7.
    Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114–1123PubMedCrossRefGoogle Scholar
  8. 8.
    Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740PubMedCrossRefGoogle Scholar
  9. 9.
    Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M et al (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29(23):3163–3172PubMedCrossRefGoogle Scholar
  10. 10.
    Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10):1215–1223PubMedCrossRefGoogle Scholar
  11. 11.
    Stephens RJ, Thompson LC, Quirke P, Steele R, Grieve R, Couture J et al (2010) Impact of short-course preoperative radiotherapy for rectal cancer on patients’ quality of life: data from the medical research council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol 28(27):4233–4239PubMedCrossRefGoogle Scholar
  12. 12.
    Tiv M, Puyraveau M, Mineur L, Calais G, Maingon P, Bardet E et al (2010) Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial. Cancer Radiother 14(6–7):530–534PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of Clinical OncologyUniversity of Leeds, St James’s Institute of Oncology, St James’s University HospitalLeedsUK
  2. 2.Department of Clinical OncologyMount Vernon Centre for Cancer TreatmentNorthwood, MiddlesexUK

Personalised recommendations